Furthermore, mice bearing isogenic tumors transplanted with Eμ-Myc lymphomas exhibited remarkable regression and apoptotic cell death when treated with a CHK1 inhibitor, highlighting its therapeutic potential. Here, CHEK1 is linked to lymphoma.